Based on the three independent variables (i.e., first induction response, cytogenomic risk, and TP53 gene status) obtained from the multivariate analysis (Fig. 5a), we sought to develop a scoring model for predicting OS in pediatric AML. This evidence concerns the gene TP53 and acute myeloid leukemia.